Prof. Yin Li 李印
Chief Physician, Professor
Department of Thoracic Surgery, Cancer Hospital, Chinese Academy of Medical Sciences (National Cancer Center), Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Minimally invasive surgery and comprehensive care for esophageal cancer, cardia cancer, lung cancer, mediastinal tumors, and other complex thoracic diseases.
Dr. Li is Director of Esophageal and Mediastinal Tumor Surgery at Cancer Hospital, Chinese Academy of Medical Sciences. A professor and doctoral supervisor, Dr. Li holds a medical doctorate and is a Fellow of the Royal College of Surgeons of England. Dr. Li serves as chief expert for minimally invasive esophageal cancer surgery in national advanced training programs and receives special government allowances.
Professional roles
- Chair, Esophageal Cancer Expert Committee and Enhanced Recovery Expert Committee, Chinese Medical Doctor Association
- Vice Chair, Esophageal Cancer Professional Committee, China Anti-Cancer Association
- Vice Chair, Thoracic Surgery Branch, China International Exchange and Promotion Association for Medical and Healthcare
- Member, Thoracic and Cardiovascular Surgery Branch, Chinese Medical Association
Name order: in Chinese the family name comes first (Li Yin). Papers usually list the name as Yin Li or Li Y.
Selected publications
127 papers on PubMed matched by name and affiliation; 34 as first or senior author since 2016. Most recent first- or senior-author papers:
- MedComm (2020), 2026 (senior author): Advocating for Precision Neoadjuvant and Subsequent Adjuvant Therapies in Esophageal Squamous Cell Carcinoma: Evidence From a Real-World Multicenter Study. PubMed 42602445
- Signal Transduct Target Ther, 2025 (senior author): Single-cell atlas of the esophageal squamous cell carcinoma immune ecosystem to predict immunotherapy response. PubMed 41111072
- Thorac Cancer, 2025 (senior author): Lymph Node Metastasis for pN+ Superficial Esophageal Squamous Cell Carcinoma. PubMed 39777993
- Thorac Cancer, 2024 (first author): Changes in the recent three decades and survey on the current status of surgical treatment for esophageal cancer in China. PubMed 39031011
- J Thorac Cardiovasc Surg, 2024 (senior author): Neoadjuvant chemotherapy combined with immunotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma. PubMed 38246339
- Cancer Med, 2024 (senior author): Lymph node metastases in middle and upper mediastinum of Siewert type II adenocarcinoma: A real-world retrospective study. PubMed 38466235
- BMC Med, 2023 (first author): Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for locally advanced ESCC: a randomized Phase II clinical trial : A randomized clinical trial of neoadjuvant therapy for ESCC. PubMed 36882775
- Front Surg, 2022 (senior author): A population-based investigation: How to identify high-risk T1-2N0 esophageal cancer patients?. PubMed 36733675
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion